263 related articles for article (PubMed ID: 21912600)
1. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.
Hanvesakul R; Kubal C; Moore J; Neil D; Cook M; Ball S; Briggs D; Moss P; Cockwell P
PLoS One; 2011; 6(8):e23631. PubMed ID: 21912600
[TBL] [Abstract][Full Text] [Related]
2. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
4. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
5. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
6. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation.
Hanvesakul R; Spencer N; Cook M; Gunson B; Hathaway M; Brown R; Nightingale P; Cockwell P; Hubscher SG; Adams DH; Moss P; Briggs D
Am J Transplant; 2008 Sep; 8(9):1931-41. PubMed ID: 18671674
[TBL] [Abstract][Full Text] [Related]
7. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
[TBL] [Abstract][Full Text] [Related]
8. KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts.
Marcenaro E; Pesce S; Sivori S; Carlomagno S; Moretta L; Moretta A
Blood; 2013 Apr; 121(17):3396-401. PubMed ID: 23449637
[TBL] [Abstract][Full Text] [Related]
9. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.
Tran TH; Middleton D; Döhler B; Scherer S; Meenagh A; Sleator C; Opelz G
Am J Transplant; 2009 Jul; 9(7):1674-8. PubMed ID: 19392983
[TBL] [Abstract][Full Text] [Related]
11. Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.
La Manna G; Corsini S; Iannelli S; Cappuccilli ML; Comai G; Iorio M; Todeschini P; Carretta E; Scolari MP; Bontadini A; Stefoni S
Ann Transplant; 2013 Nov; 18():611-21. PubMed ID: 24220609
[TBL] [Abstract][Full Text] [Related]
12. Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
Sekine T; Marin D; Cao K; Li L; Mehta P; Shaim H; Sobieski C; Jones R; Oran B; Hosing C; Rondon G; Alsuliman A; Paust S; Andersson B; Popat U; Kebriaei P; Muftuoglu M; Basar R; Kondo K; Nieto Y; Shah N; Olson A; Alousi A; Liu E; Sarvaria A; Parmar S; Armstrong-James D; Imahashi N; Molldrem J; Champlin R; Shpall EJ; Rezvani K
Blood; 2016 Jul; 128(2):297-312. PubMed ID: 27247137
[TBL] [Abstract][Full Text] [Related]
13. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
[TBL] [Abstract][Full Text] [Related]
14. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
[TBL] [Abstract][Full Text] [Related]
15. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
Callemeyn J; Senev A; Coemans M; Lerut E; Sprangers B; Kuypers D; Koenig A; Thaunat O; Emonds MP; Naesens M
J Am Soc Nephrol; 2021 Aug; 32(8):2070-2082. PubMed ID: 34301794
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
[TBL] [Abstract][Full Text] [Related]
17. Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.
Marcenaro E; Cantoni C; Pesce S; Prato C; Pende D; Agaugué S; Moretta L; Moretta A
Blood; 2009 Nov; 114(19):4108-16. PubMed ID: 19749090
[TBL] [Abstract][Full Text] [Related]
18. Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive Subsets.
Hitz AM; Bläsing KA; Wiegmann B; Bellmàs-Sanz R; Chichelnitskiy E; Wandrer F; Horn LM; Neudörfl C; Keil J; Beushausen K; Ius F; Sommer W; Avsar M; Kühn C; Tudorache I; Salman J; Siemeni T; Haverich A; Warnecke G; Falk CS; Kühne JF
Front Immunol; 2021; 12():778885. PubMed ID: 34966390
[TBL] [Abstract][Full Text] [Related]
19. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection.
Legaz I; Bolarín JM; Campillo JA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Álvarez-López MR
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293011
[TBL] [Abstract][Full Text] [Related]
20. NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs.
Ichise H; Nagano S; Maeda T; Miyazaki M; Miyazaki Y; Kojima H; Yawata N; Yawata M; Tanaka H; Saji H; Masuda K; Kawamoto H
Stem Cell Reports; 2017 Sep; 9(3):853-867. PubMed ID: 28867344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]